Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3822376

CN1CCNCCC1=O.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.41
HRH4 Q9H3N8 2/20 0.38
BRD4 O60885 1/20 0.38
BRD2 P25440 1/20 0.38
HRH3 Q9Y5N1 1/20 0.36
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
IRAK4 Q9NWZ3 4/20 0.31
SIGMAR1 Q99720 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
RAD52 P43351 1/20 0.31
UBE2N P61088 1/20 0.31
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
ALDH1A1 P00352 1/20 0.30
RAB9A P51151 1/20 0.30
ADORA2A P29274 1/20 0.30
SLC2A1 P11166 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2912515 0.85 PKM (0.39) PKMHRH4BRD4BRD2HRH3
SCHEMBL2916060 0.84
Hydrochloric Acid SCHEMBL750994 0.82 BRD4 (0.50) BRD4BRD2HTR2AHTR2CKDM4E
Hydrochloric Acid SCHEMBL31114147 0.82 BRD4 (0.50) BRD4BRD2HTR2AHTR2CKDM4E
Methylpyrrolidone SCHEMBL29566005 0.79 BRD4 (0.65) BRD4BRD2L3MBTL1ALDH1A1
Trifluoroacetic Acid SCHEMBL19260537 0.77 BRD4 (0.57) HRH4BRD4BRD2HRH3L3MBTL1
Methylpiperazine SCHEMBL2263099 0.76 PKM (0.44) PKMHRH4HRH3HTR2AHTR2C
Methylpiperazine SCHEMBL2267453 0.76 PKM (0.44) PKMHRH4HRH3HTR2AHTR2C
Trifluoroacetic Acid SCHEMBL4307037 0.74 PKM (0.36) PKMHRH4HTR2AHTR2C
SCHEMBL13259171 0.72 BRD4 (0.60) BRD4BRD2HTR2AHTR2CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730148-A4 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS ABBOTT LAB (US) 2009-08-19 EP disclosed
EP-1730148-A2 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS Abbott Laboratories (US) 2006-12-13 EP disclosed
US-20060025383-A1 Aminobenzoxazoles as therapeutic agents ABBOTT LABORATORIES 2006-02-02 US disclosed
WO-2005074603-A2 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS ABBOTT LABORATORIES (US) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025383-A1 Aminobenzoxazoles as therapeutic agents ABL1, MAP3K19, MAP3K20 PKM 552/4885HRH4 3140/4885BRD4 310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.